The most common forms of extended difficulty were feelings of anxiety and fear, existential struggle, social disconnection, depersonalization and derealization.

For approximately one-third of the participants, problems persisted for over a year, and for a sixth, they endured for more than three years.

It was found that a shorter duration of difficulties was predicted by knowledge of dose, drug type and lower levels of difficulty reported during the psychoactive experience, while a narrower range of difficulties was predicted by taking the drug in a guided setting.

Intensity of Psychedelic Experience

November 8, 2023 Lynne Nardizzi

A new study suggests that dosage, age, and neuroticism may predict the intensity of a psychedelic experience, whether mystical (positive) or challenging.

Psilocybin and Adverse Childhood Experiences

October 23, 2023 Lynne Nardizzi

In this new study, findings suggest that psilocybin therapy may be potentially acceptable and may feasibly help in supporting survivors of adverse childhood experiences with particularly strong benefits to those with more severe childhood adversity.

Psychedelics for OCD?

October 22, 2023 Lynne Nardizzi

A team of researchers has analysed the experience of people with Obsessive-Compulsive Disorder (OCD) who have taken psychedelics, finding 30% experienced relief from their symptoms.

DMT and SSRIs

October 5, 2023 Lynne Nardizzi

This new study showed that after 4 weeks, all patients who took SSRIs in combination with DMT showed full responsiveness, achieving a 100% success rate.

Additionally, 92% experienced remission from depression.

Psychiatrists Have Positive Attitude Towards Psychedelics

October 2, 2023 Lynne Nardizzi

This recent study shows a striking positive shift in attitudes toward the therapeutic potential of hallucinogens among American psychiatrists since 2016, with a majority of responding psychiatrists planning to incorporate hallucinogen-assisted therapy into their practice if regulatory approval is granted.

New Psilocybin Research

September 25, 2023 Lynne Nardizzi

This recently published study showed that psilocybin use is associated with persisting improvements in mental health and wellbeing.

Mindfulness and Psychedelics

August 21, 2023 Lynne Nardizzi

A new study links mindfulness meditation and psychedelic use to positive leadership outcomes at work.

Psychedelics- An Update

August 17, 2023 Lynne Nardizzi

Psychedelic Science 2023 brought together 12,000 registrants in Denver, Colorado, four times as many people as the previous conference in 2017, crowning the movement to rehabilitate psychedelics for therapeutic use against depression and other disorders.

Science unveils unsuspected mechanisms of brain reconfiguration and ends decades of research bans imposed by the war on drugs, but serious obstacles remain to be overcome.